![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2](https://ars.els-cdn.com/content/image/1-s2.0-S016041202100670X-ga1.jpg)
benzoapyrene phase 2 glutathione s transferase
benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2
benzo a pyrene phase 2 glutathione s transferase Benzo[a]pyrene induced nephrotoxicity driven by intricate A novel framework for polycyclic aromatic hydrocarbon doseeffect assessment: A case study of benzo[a]pyrene ScienceDirect Metabolic pathway of BaP benzo[a]pyrene (BaP), benzo[a]pyrene 7, Download Scientific Diagram Benzo[a]pyreneEnvironmental Occurrence, Human Exposure, and Mechanisms of Toxicity PMC
USD23.72
USD58.72
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2](https://www.frontiersin.org/files/Articles/1633648/xml-images/fmicb-16-1633648-g004.webp)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2](https://ars.els-cdn.com/content/image/1-s2.0-S0160412026002035-ga1.jpg)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2](https://www.researchgate.net/publication/26332727/figure/fig3/AS:669332065513493@1536592608391/Metabolic-pathway-of-BaP-benzoapyrene-BaP-benzoapyrene-7.png)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP benzo a pyrene phase 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad6/9181839/ff47c629a5e7/ijms-23-06348-g006.jpg)